Global Demineralized Bone Matrix Market Insights Forecasts to 2033

• The Global Demineralized Bone Matrix Market Size was Valued at USD 1.35 Billion in 2023
• The Market Size is Growing at a CAGR of 5.65% from 2023 to 2033
• The Worldwide Demineralized Bone Matrix Market Size is Expected to Reach USD 2.34 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Demineralized Bone Matrix Market Size is Anticipated to Exceed USD 2.34 Billion by 2033, Growing at a CAGR of 5.65% from 2023 to 2033.

Market Overview

An allograft type utilized for spinal fusion and bone abnormalities is called a demineralized bone matrix. Bone morphogenetic proteins (BMPs) that are more physiologically active are revealed during this process of removing bone material. The creation of cartilage and bones is carried out by these BMP growth factors, which alter progenitor cells' variety into osteoprogenitor cells. To aid in the creation of new bone and cartilage, these bone solutions are used to support and repair cracked bones. A rising number of patients are receiving bone therapies as a result of the rise in trauma and spine surgeries. This is propelling the demand for demineralized bone matrix products throughout the world's healthcare environments. The aging population is also a significant issue since orthopedic conditions including osteoarthritis, fractures, dislocations, and osteoporosis are prevalent in older people. A lack of movement and growth in sports-related injuries, drive up demand for orthopedic surgeries and treatments, such as bone grafting and bone regeneration using these materials. Additionally, for instance, information gathered from the Ministry of Health and Family Welfare (MoHFW) and the National Institute of Health and Family Welfare (NIHFW) of the Government of India indicates that osteoarthritis is the most commonly diagnosed joint disease in India and the second most common rheumatologic problem in the country.

Report Coverage

This research report categorizes the market for the demineralized bone matrix market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the demineralized bone matrix market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the demineralized bone matrix market.

Driving Factors

The market is rising due in addition to the growing demand and adoption of less invasive surgical procedures. There are various advantages to minimally invasive surgical treatments, including reduced discomfort, fewer problems, and quicker recovery. Minimally invasive procedures are carried out using a demineralized bone matrix. The market is developing due to increased R&D in the demineralized bone matrix region, technology developments, rising healthcare costs, and an increase in the number of patients with orthopedic and dental illnesses.

Restraining Factors

Demineralized bone matrix products have experienced considerable improvements including modifications to their designs. However, due to the precise manufacturing process and the high cost of keeping the product in a sterile environment, bone transplant treatments and demineralized bone matrix are quite expensive.

Market Segmentation

The demineralized bone matrix market share is classified into product, application, and end user.

• The putty segment dominates the market with the highest market share through the forecast period.

Based on the product, the demineralized bone matrix market is categorized into gel, putty, and others. Among these, the putty segment dominates the market with the highest market share through the forecast period. Due to various factors, including the increasing number of dental disorders, the growing prevalence of orthopedic diseases, including the increased use of putty products. Putty's ease of shaping and molding to fit different anatomical areas, increased stability and structural support for bone healing, and adaptability in filling and contouring bone cavities or gaps.

• The spinal fusion segment predicted to account the largest revenue share through the forecast period.

Based on the application, the demineralized bone matrix market is categorized into dental, craniomaxillofacial, spinal fusion, long bone procedures, joint reconstruction, and others. Among these, the spinal fusion segment predicted to account the largest revenue share through the forecast period. Due to the surge in the number of spine surgeries or fusion procedures among patients with spinal disorders. Demand for minimally invasive spinal fusion treatments is rising due to several factors, including the aging population with spinal problems and chronic back pain, favorable medical results in obtaining spinal fusion and stability, technological developments in spinal implants and surgical techniques, and increased patient demand.

• The hospital segment is anticipated to grow at the fastest market share through the forecast period.

Based on the end user, the demineralized bone matrix market is categorized into hospital, specialty clinics, and others. Among these, the hospital segment is anticipated to grow at the fastest market share through the forecast period. Because hospitals are performing more bone graft treatments for orthopedic and dental care procedures. In both wealthy and developing nations, hospitals offer suitable reimbursement policies.

Regional Segment Analysis of the Demineralized Bone Matrix Market 

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the demineralized bone matrix market over the predicted timeframe.

North America is projected to hold the largest share of the demineralized bone matrix market over the forecast period. The North American market is growing primarily due to factors like the availability of advanced healthcare infrastructure and technological capabilities, the rising incidence of orthopedic surgeries and bone-related disorders, and favorable reimbursement policies for bone grafting procedures. The strong presence of important market players, rising investments in regenerative medicine research and development, and ongoing product advances all contribute to the growth of the North American market.

Asia Pacific is expected to grow at the fastest CAGR growth in the demineralized bone matrix market during the forecast period. The APAC market is growing primarily due to the region's wide population, rising healthcare costs, rising number of patients with orthopedic conditions and trauma injuries, and developing nations' increased access to and infrastructure for healthcare. The APAC market is expanding at a faster rate additionally due to the quick adoption of advanced implants and surgical methods along with rising investments in tissue engineering and regenerative medicine.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the demineralized bone matrix market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Zimmer
• Biomet
• Stryker
• Xtant Medical
• Straumann
• Orthofix Holdings,Inc.
• RTI Surgical
• Medtronic Plc
• Arthrex GmbH
• Seaspine Holdings Corporation
• Institut Straumann AG
• Halma plc
• Johnson & Johnson
• DePuy Synthes 
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In January 2023, Orthofix Medical Inc. and SeaSpine combined to expand their line of biologics products, bone-growth treatments, and orthopaedic products.

• In September 2022, Ossifix Orthopedics, a subsidiary of Umbra utilized Technologies Group Inc. initiated a new demineralized bone matrix product.

.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the demineralized bone matrix market based on the below-mentioned segments: 

Global Demineralized Bone Matrix Market, By Product

• Gel
• Putty
• Others

Global Demineralized Bone Matrix Market, By Application

• Dental
• Craniomaxillofacial
• Spinal fusion
• Long bone procedures
• Joint reconstruction
• Others

Global Demineralized Bone Matrix Market, By End User

• Hospital
• Specialty clinics
• Others

Global Demineralized Bone Matrix Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa